Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-02

Clinical Trial Update: Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the herbal medicine C117 to prevent restenosis after intracranial artery stent implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • C117

Snippet

Sponsor: Guangzhou University of Traditional Chinese Medicine | Conditions: Occlusion and Stenosis of Unspecified Cerebral Artery | Phase 2 | Status: UNKNOWN